Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Br J Dermatol. 2024 Jan 23;190(2):258-265. doi: 10.1093/bjd/ljad369.
Br J Dermatol. 2024.
PMID: 37792727
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study.
Navarini AA, Prinz JC, Morita A, Tsai TF, Viguier MA, Li L, Thoma C, Sivalingam M, Lebwohl MG.
Navarini AA, et al. Among authors: viguier ma.
J Eur Acad Dermatol Venereol. 2023 Apr;37(4):730-736. doi: 10.1111/jdv.18820. Epub 2023 Jan 23.
J Eur Acad Dermatol Venereol. 2023.
PMID: 36527385
Clinical Trial.
Item in Clipboard
Significantly reduced duration of antibiotic prescription for erysipelas subsequent to the 2019 French guidelines on skin and soft tissue infection: A before-after study.
Destoop J, Vanhaecke C, Bani-Sadr F, Plenier Y, Viguier MA, Hentzien M.
Destoop J, et al. Among authors: viguier ma.
Infect Dis Now. 2024 Apr;54(3):104887. doi: 10.1016/j.idnow.2024.104887. Epub 2024 Mar 15.
Infect Dis Now. 2024.
PMID: 38492802
Item in Clipboard
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators.
Bachelez H, et al.
N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563.
N Engl J Med. 2021.
PMID: 34936739
Free article.
Clinical Trial.
Item in Clipboard
[Update of the French recommendations for the management of pemphigus].
Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).
Jelti L, et al. Among authors: viguier ma.
Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29.
Ann Dermatol Venereol. 2019.
PMID: 30929874
French.
No abstract available.
Item in Clipboard
Cite
Cite